GDTC vs JSPR
Comparison between CytoMed Therapeutics Ltd (GDTC, Company) and Jasper Therapeutics Inc (JSPR, Company).
Both GDTC and JSPR are from the Healthcare sector.
GDTC vs JSPR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
GDTC
$13M
JSPR
$13M
Max Drawdown
Winner
GDTC
87.18%
JSPR
99.72%
Sharpe Ratio
Winner
GDTC
-0.35
JSPR
-1.75
5Y Beta
Winner
GDTC
0.51
JSPR
1.40
Industry
GDTC
Biotechnology
JSPR
Biotechnology
P/E Ratio
Winner
GDTC
-3.49
JSPR
-0.17
PEG Ratio
GDTC
-0.20
JSPR
N/A
Debt to Equity
GDTC
7.37%
Winner
JSPR
0.00%
Free Cash Flow Yield
GDTC
-37.64%
JSPR
N/A
GDTC vs JSPR - Historical Returns
Returns include dividend reinvestment.
1M
Winner
GDTC
-10.74%
JSPR
-43.83%
3M
Winner
GDTC
+2.85%
JSPR
-62.87%
6M
Winner
GDTC
-30.77%
JSPR
-75.65%
1Y
Winner
GDTC
-53.65%
JSPR
-91.39%
5Y(CAGR)
GDTC
N/A
JSPR
-70.72%
Max(CAGR)
Winner
GDTC
-33.76%
JSPR
-70.72%
GDTC vs JSPR - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | GDTC | JSPR |
|---|---|---|
| 2026 | -22.30% | -75.38% |
| 2025 | -61.86% | -91.32% |
| 2024 | -22.90% | +214.13% |
| 2023 | +22.50% | -71.20% |
| 2022 | N/A | -93.97% |
| 2021 | N/A | -48.08% |
GDTC vs JSPR Drawdown Comparison
The maximum drawdown for GDTC was -87.18%, occurring on May 7, 2026. This drawdown has not yet recovered.
The maximum drawdown for JSPR was -99.72%, occurring on Jun 16, 2026. This drawdown has not yet recovered.
The current GDTC drawdown is -80.85%. The current JSPR drawdown is -99.72%.
| Rank | GDTC | JSPR |
|---|---|---|
| #1 | -87.18% Jul 11, 2023 - May 7, 2026 | -99.72% Oct 15, 2021 - Jun 16, 2026 |
| #2 | -39.23% May 8, 2023 - Jul 11, 2023 | -52.31% Sep 24, 2021 - Oct 15, 2021 |
| #3 | -18.75% Apr 14, 2023 - May 8, 2023 | N/A |
Correlation
Correlation between GDTC and JSPR is 0.22 which considered as a very weak or no correlation - the stocks move independently of each other.
0.22
-101
Select Stocks to Compare
Popular: GDTC vs SPYJSPR vs SPY
More Comparisons
Compare with similar stocks